Diagnostic value of Ischaemia-modified albumin for predicting myocardial ischaemia during myocardial perfusion scintigraphy

Journal of International Medical Research

Volumn 36, Issue 1, 2008, Pages 147-151

  Cingozbay, B Y ^a   Özmen, Namik ^a,b   Canbolat, N ^a   Aparci, M ^a   Kardesoglu E ^a   Narin, Y ^a   Gultepe, M ^a   Cebeci, B S ^a   Dincturk, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Angina pectoris; Diagnosis; Ischaemia modified albumin; Myocardial ischaemia; Myocardial perfusion scintigraphy

Indexed keywords

ALBUMINOID; ISCHEMIA MODIFIED ALBUMIN; TECHNETIUM 99M;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE MARKER; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; PROTEIN DETERMINATION; PROTEIN MODIFICATION; SENSITIVITY ANALYSIS; STABLE ANGINA PECTORIS;

EID: 39149096871     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600118     Document Type: Article

References (18)

1. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000; 19: 311-315.
2. McCord JM: Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985; 312: 159-163.
3. Cobbe SM, Poole-Wilson PA: The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol 1980; 12: 745-760.
4. Berenshtein E, Mayer B, Goldberg C, et al: Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 1997; 29: 3025-3034.
5. Sinha MK, Roy D, Gaze DC, et al: Role of 'Ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21: 29-34.
6. Worster A, Devereaux PJ, Heels-Ansdell D, et al: Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005; 172: 1685-1690.
7. Sinha MK, Gaze DC, Tippins JR, et al: Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107: 2403-2405.
8. Campeau L: Grading of angina pectoris. Circulation 1976; 54: 522-523.
9. Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
10. Klocke FJ, Baird MG, Lorell BH, et al: ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging-Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003; 108: 1404-1418.
11. Apple FS, Quist HE, Otto AP, et al: Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48: 1097-1100.
12. Roy D, Quiles J, Sharma R, et al: Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004; 50: 1656-1660.
13. Roy D, Quiles J, Aldama G, et al: Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004; 97: 297-301.
14. Roy D, Quiles J, Sinha M, et al: Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 2004; 93: 366-368.
15. Barceloux DG: Cobalt. Toxicol Clin Toxicol 1999; 37: 201-206.
16. Dery MA, Michaud MD, et al: Hypoxia-inducible factor-1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005; 37: 535-540.
17. Xi L, Taher M, Yin C, et al: Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1a and AP-1 and NOS signaling. Am J Physiol Heart Circ Physiol 2004; 287: H2369-H2375.
18. Gugliucci A, Hermo R, Monroy C, et al: Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005; 362: 155-160.